SEC registrant · CIK 0001124608

RESPONSE GENETICS INC

RESPONSE GENETICS INC (CIK 0001124608) reported revenue of $16.72 million ($16,720,327) for FY2014 (2014-01-01 to 2014-12-31) and net income of -$13.7 million (-$13,699,362) for FY2014 (2014-01-01 to 2014-12-31), as filed in its 10-K filed 2015-03-31 (accession 0001144204-15-020185).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001124608
EINnot in EDGAR (or not a valid EIN)
SIC industry code2835 In Vitro & In Vivo Diagnostic Substances
Fiscal year endDecember 31
Filer categorySmaller reporting company
Entity typeoperating
Olympus entity IDorg_4nwxh17ea9ww68j8ba70tc4spj
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$16,720,327FY20142014-01-01 to 2014-12-3110-K2015-03-310001144204-15-020185SalesRevenueNet
Net income-$13,699,362FY20142014-01-01 to 2014-12-3110-K2015-03-310001144204-15-020185NetIncomeLoss
Total assets$13,445,084FY2014as of 2014-12-3110-K2015-03-310001144204-15-020185Assets
Total liabilities$14,615,191FY2014as of 2014-12-3110-K2015-03-310001144204-15-020185Liabilities
Stockholders' equity-$1,170,107FY2014as of 2014-12-3110-K2015-03-310001144204-15-020185StockholdersEquity
Operating cash flow-$14,300,075FY20142014-01-01 to 2014-12-3110-K2015-03-310001144204-15-020185NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.35 per shareFY20142014-01-01 to 2014-12-3110-K2015-03-310001144204-15-020185EarningsPerShareDiluted
Shares outstanding38,795,396 sharesFY2014as of 2015-03-2610-K2015-03-310001144204-15-020185EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2005-2014, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20142014-01-01 to 2014-12-31$16,720,32710-K2015-03-310001144204-15-020185
RevenueFY20132013-01-01 to 2013-12-31$19,801,35910-K2015-03-310001144204-15-020185
RevenueFY20122012-01-01 to 2012-12-31$18,736,66910-K2014-03-310001144204-14-019296
RevenueFY20112011-01-01 to 2011-12-31$22,642,72810-K2013-03-270001144204-13-017755
Net incomeFY20142014-01-01 to 2014-12-31-$13,699,36210-K2015-03-310001144204-15-020185
Net incomeFY20132013-01-01 to 2013-12-31-$8,020,51510-K2015-03-310001144204-15-020185
Net incomeFY20122012-01-01 to 2012-12-31-$7,757,07910-K2014-03-310001144204-14-019296
Net incomeFY20112011-01-01 to 2011-12-31-$5,702,42210-K2013-03-270001144204-13-017755

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2015-05-152015-03-310001144204-15-031665v409754_10q.htm
10-K2015-03-312014-12-310001144204-15-020185v404659_10k.htm
10-Q2014-11-142014-09-300001144204-14-068641v393463_10q.htm
10-Q2014-08-142014-06-300001144204-14-050100v386133_10q.htm
10-Q2014-05-152014-03-310001144204-14-031203v377240_10q.htm
10-K2014-03-312013-12-310001144204-14-019296v370770_10k.htm
10-Q2013-11-142013-09-300001144204-13-061798v358798_10q.htm
10-Q2013-08-132013-06-300001144204-13-045019v352164_10q.htm
10-Q2013-05-152013-03-310001144204-13-028990v343502_10q.htm
10-K/A2013-04-292012-12-310001144204-13-024756v343002_10ka.htm
10-K2013-03-272012-12-310001144204-13-017755v336811_10k.htm
10-Q2012-11-142012-09-300001144204-12-062220v325758_10q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001124608published by the sourcedata.sec.gov/submissions/CIK0001124608.json2026-10-21

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001124608.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001124608.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001124608" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001124608/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001124608/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1124608"}

On SEC EDGAR

About this data